Medtronic's Q3 sales rise 4.7%: 5 notes

Spinal Tech

Medtronic on Feb. 20 posted $8.1 billion in sales for the third quarter of fiscal year 2024.

Five things to know:

1. Quarterly sales rose 4.7% year over year.

2. Medtronic's cranial and spinal technologies segment saw $1.2 billion in quarterly sales, an increase of 6.7% year over year.

3. The company's full neuroscience portfolio saw $2.3 billion in sales, up 4.8% year over year.

4. Medtronic's medical surgical portfolio grew 3.9% year over year with $2.1 billion in sales. The cardiovascular portfolio netted $2.9 billion in sales, a 6.1% increase year over year.

5. Medtronic raised its guidance for fiscal year 2024 and expects to see full-year growth of 4.75% to 5% year over year.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers